Disruptive Technology for Clinical Trials Europe 2025 Speakers

Cristina De Juan PhD of UCB speaking at AMG World

Cristina De Juan PhD

Global Clinical Sciences & Operations Innovation Lead

UCB

Paul Cooper of Roche speaking at AMG World

Paul Cooper

Personalised Healthcare Strategy Leader

Roche

Dr Fabian Kreimendahl of The Janssen Pharmaceutical Companies of Johnson & Johnson speaking at AMG World

Dr Fabian Kreimendahl

Medical Evidence Biostatistics Manager

The Janssen Pharmaceutical Companies of Johnson & Johnson

Marta Carrasco of Roche speaking at AMG World

Marta Carrasco

Data Insights Development Leader

Roche

Ming-Yuang Tseng MD PHD of AstraZeneca speaking at AMG World

Ming-Yuang Tseng MD PHD

Director Global Regulatory Affairs (CVRM)

AstraZeneca

Richardus Vonk of Bayer speaking at AMG World

Richardus Vonk

Former VP, Head Oncology Data Analytics and Statistical Science

Bayer

Dr Daphne Hazell of Home Wound Care speaking at AMG World

Dr Daphne Hazell

CEO

Home Wound Care

Samantha Warden of GSK speaking at AMG World

Samantha Warden

Global Head, Clinical Programming & Business Excellence

GSK

Sridevi Nagarajan of TBA speaking at AMG World

Sridevi Nagarajan

Head, R&D Digital

TBA

Andrew Gvozdanovic of Novo Nordisk speaking at AMG World

Andrew Gvozdanovic

International Medical Manager

Novo Nordisk

Dr Sachin S Shah of GSK speaking at AMG World

Dr Sachin S Shah

Digital Biomarker Lead

GSK

Alexandre Malouvier of ICON PLC speaking at AMG World

Alexandre Malouvier

Senior Director Scientific Affairs & Digital Innovation

ICON PLC

Piotr Maślak of AstraZeneca speaking at AMG World

Piotr Maślak

Director, Operational Data Intelligence

AstraZeneca